FOA Title: 
Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required)
Grant Type: 
RFA-AG-20-050
Primary IC: 
NIA
Release Date: 
Sep 27 2019
Expiration Date: 
Jan 31 2020
AC Source: 
R61/R33
Purpose: 
This Funding Opportunity Announcement (FOA) invites applications to pursue development and validation studies of cognitive screening instruments or assessments in clinical settings and to translate these screening and assessment tools into electronic health record (EHR) systems that can assist physicians in making clinically meaningful care recommendations for patients experiencing cognitive decline. This FOA will support an R61 pilot phase (Stage I) which will allow researchers to develop and validate tools for cognitive assessment and then create scalable, tailored interventions for patients experiencing cognitive decline to help overcome barriers to uptake. If successful, researchers may transition to an R33 phase (Stage IV) for implementation of pragmatic trials. All applicants are required to address health disparities. This FOA does not require preliminary data.